Activation of the Mechanistic Target of Rapamycin in SLE: Explosion of Evidence in the Last Five Years

Por Oaks, Zachary, Winans, Thomas, Huang, Nick, Banki, Katalin, Perl, Andras
Publicado no Curr Rheumatol Rep (2016)

Mitochondrial Dysfunction in the Liver and Antiphospholipid Antibody Production Precede Disease Onset and Respond to Rapamycin in Lupus‐Prone Mice

Por Oaks, Zachary, Winans, Thomas, Caza, Tiffany, Fernandez, David, Liu, Yuxin, Landas, Steve K., Banki, Katalin, Perl, Andras
Publicado no Arthritis Rheumatol (2016)

Sirolimus in patients with clinically active systemic lupus erythematosus resistant to, or intolerant of, conventional medications: a single-arm, open-label, phase 1/2 trial

Por Lai, Zhi-Wei, Kelly, Ryan, Winans, Thomas, Marchena, Ivan, Shadakshari, Ashwini, Yu, Julie, Dawood, Maha, Garcia, Ricardo, Tily, Hajra, Francis, Lisa, Faraone, Stephen V, Phillips, Paul E, Perl, Andras
Publicado no Lancet (2018)